2c69
From Proteopedia
(Difference between revisions)
Line 20: | Line 20: | ||
==About this Structure== | ==About this Structure== | ||
- | 2C69 is a | + | 2C69 is a 1 chain structure of sequence from [http://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2C69 OCA]. |
==Reference== | ==Reference== | ||
- | + | <ref group="xtra">PMID:16325401</ref><references group="xtra"/> | |
[[Category: Homo sapiens]] | [[Category: Homo sapiens]] | ||
[[Category: Non-specific serine/threonine protein kinase]] | [[Category: Non-specific serine/threonine protein kinase]] | ||
- | [[Category: Single protein]] | ||
[[Category: Dokurno, P.]] | [[Category: Dokurno, P.]] | ||
[[Category: Murray, J B.]] | [[Category: Murray, J B.]] | ||
Line 44: | Line 43: | ||
[[Category: Triazolopyrimidine inhibitor]] | [[Category: Triazolopyrimidine inhibitor]] | ||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on | + | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Feb 17 09:58:52 2009'' |
Revision as of 07:58, 17 February 2009
CRYSTAL STRUCTURE OF THE HUMAN CDK2 COMPLEXED WITH THE TRIAZOLOPYRIMIDINE INHIBITOR
Template:ABSTRACT PUBMED 16325401
About this Structure
2C69 is a 1 chain structure of sequence from Homo sapiens. Full crystallographic information is available from OCA.
Reference
- Richardson CM, Williamson DS, Parratt MJ, Borgognoni J, Cansfield AD, Dokurno P, Francis GL, Howes R, Moore JD, Murray JB, Robertson A, Surgenor AE, Torrance CJ. Triazolo[1,5-a]pyrimidines as novel CDK2 inhibitors: protein structure-guided design and SAR. Bioorg Med Chem Lett. 2006 Mar 1;16(5):1353-7. Epub 2005 Dec 1. PMID:16325401 doi:http://dx.doi.org/10.1016/j.bmcl.2005.11.048
Page seeded by OCA on Tue Feb 17 09:58:52 2009
Categories: Homo sapiens | Non-specific serine/threonine protein kinase | Dokurno, P. | Murray, J B. | Richardson, C M. | Surgenor, A E. | Atp-binding | Cdk2 | Cell cycle | Cell division | Kinase | Mitosis | Nucleotide-binding | Phosphorylation | Polymorphism | Serine/threonine protein kinase | Transferase | Triazolopyrimidine inhibitor